Chronic tendon pathology: molecular basis and therapeutic implications

Riley, Graham P. ORCID: (2005) Chronic tendon pathology: molecular basis and therapeutic implications. Expert Reviews in Molecular Medicine, 7 (5). pp. 1-25. ISSN 1462-3994

[thumbnail of Riley_-_Expert_Reviews_in_Molecular_Medicine,_2005,_7,_1-25.pdf]
PDF (Riley_-_Expert_Reviews_in_Molecular_Medicine,_2005,_7,_1-25.pdf) - Published Version
Download (1MB) | Preview


Tendons are frequently affected by chronic pain or rupture. Many causative factors have been implicated in the pathology, which until relatively recently was under-researched and poorly understood. There is now a greater knowledge of the molecular basis of tendon disease. Most tendon pathology (tendinopathy) is associated with degeneration, which is thought to be an active, cell-mediated process involving increased turnover and remodelling of the tendon extracellular matrix. Degradation of the tendon matrix is mediated by a variety of metalloproteinase enzymes, including matrix metalloproteinases and ‘aggrecanases’. Neuropeptides and other factors released by stimulated cells or nerve endings in or around the tendon might influence matrix turnover, and could provide novel targets for therapeutic intervention.

Item Type: Article
Faculty \ School: Faculty of Science > School of Biological Sciences
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Musculoskeletal Medicine
Faculty of Science > Research Groups > Cells and Tissues
Depositing User: Users 2731 not found.
Date Deposited: 18 May 2011 08:34
Last Modified: 02 Sep 2023 00:58
DOI: 10.1017/S1462399405008963


Downloads per month over past year

Actions (login required)

View Item View Item